Provided by Tiger Trade Technology Pte. Ltd.

Quest Diagnostics

195.26
+1.100.57%
Post-market: 195.260.00000.00%18:02 EDT
Volume:2.03M
Turnover:396.55M
Market Cap:21.48B
PE:22.32
High:196.83
Open:194.07
Low:192.79
Close:194.16
52wk High:213.50
52wk Low:157.20
Shares:110.00M
Float Shares:110.00M
Volume Ratio:2.72
T/O Rate:1.85%
Dividend:3.20
Dividend Rate:1.64%
EPS(TTM):8.75
EPS(LYR):8.75
ROE:14.75%
ROA:6.20%
PB:3.00
PE(LYR):22.32

Loading ...

How Investors May Respond To Quest Diagnostics (DGX) Expanding Blood-Based Cancer Screening And Boardroom Expertise

Simply Wall St.
·
Yesterday

Quest Diagnostics to report first-quarter 2026 results and host earnings call

Reuters
·
Mar 19

Quest Diagnostics Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Mar 19

Quest Diagnostics Files Initial Beneficial Ownership Statement for Director Timothy C. Wentworth

Reuters
·
Mar 12

Argus Adjusts Price Target on Quest Diagnostics to $225 From $210, Maintains Buy Rating

MT Newswires Live
·
Mar 10

Quest Diagnostics Inc : Argus Research Raises Target Price to $225 From $210

THOMSON REUTERS
·
Mar 10

Quest Diagnostics Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Mar 07

Quest Diagnostics EVP Catherine T. Doherty disposes of common shares

Reuters
·
Mar 07

Quest Diagnostics SVP and General Counsel Michael E. Prevoznik Disposes of Common Shares

Reuters
·
Mar 07

Quest Diagnostics SVP Clinical Solutions Karthik Kuppusamy Disposes of Common Shares

Reuters
·
Mar 07

Quest Diagnostics CEO and President James E. Davis Disposes of Common Shares

Reuters
·
Mar 05

Quest Diagnostics SVP for Diagnostic Services Patrick Plewman Disposes of Common Shares

Reuters
·
Mar 05

BRIEF-Quest Diagnostics Introduces Ai Companion To Help Patients Understand And Act On Lab Test Results

Reuters
·
Mar 02

Quest Diagnostics Launches Gemini-Powered AI Companion for Lab Results

Reuters
·
Mar 02

Quest Diagnostics Introduces AI Companion to Help Patients Understand and Act on Lab Test Results

THOMSON REUTERS
·
Mar 02

Quest FY 2025 equity-method investee earnings hit USD 42 million (+120.5%)

Reuters
·
Feb 27

Quest Diagnostics Names Benjamin Beauvalot Chief Strategy and M&A Officer

Reuters
·
Feb 26

Quest Diagnostics Names Benjamin Beauvalot Senior Vice President, Chief Strategy and M&a Officer

THOMSON REUTERS
·
Feb 26

Quest Diagnostics CFO Sam Samad to Speak at Leerink 2026 Global Healthcare Conference

Reuters
·
Feb 25

Quest Diagnostics SVP and General Counsel Michael E. Prevoznik Disposes of Common Shares

Reuters
·
Feb 21